Performing high-quality epidermal growth factor receptor (EGFR) mutation testing is key to making informed treatment decisions for non-small cell lung cancer (NSCLC) patients.
AstraZeneca, in collaboration with experts across the globe, has developed an educational resource that covers each step in the EGFR mutation testing process.
Broken into bite-sized sections, the modules are designed to help clinicians and laboratory scientists adopt Close Window best practice in EGFR mutation testing .
This comprehensive resource includes:
- Why test NSCLC patients for their EGFR mutation status
- Which mutations should be screened?
- Ordering a test
- Sample acquisition and logistics
- Pathology review and sample preparation
- Mutation testing methods and laboratory requirements
- Reporting test results and making a treatment decision
